What's New in Research Funding

Page last updated July 20, 2017.

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates:

July 20, 2017
 

  • CIHR Foundation Grant Update. The Acting President of the Canadian Institutes of Health Research, Dr. Roderick McInnes, has announced an update to its Foundation Grant program.  Of note the following changes have been made to the program effective with the 2017-18 competition:
    • The total funding envelope for the Foundation Grant program will be reduced from $200M to $125M, with the $75M reduction will be redirected to the Project Grant program.
    • Early career investigators (ECIs) will not be eligible to apply to the Foundation Grant program; starting with the 2017-18 competition, but CIHR will ensure that the success rate of ECIs is equalized in the Project Grant program.  Any ECIs who have already submitted a registration to the current 2017-18 competition will have their registrations withdrawn.
       
  • Ted Rogers Centre for Heart Research: Innovation Fund Strategic Grants - DEADLINE EXTENDED. The Ted Rogers Centre for Heart Research is now accepting submissions for its first-ever strategic grants, which provide funding of up to $1 million over 3 years for transformative research projects focused on discovery, development and implementation of next-generation approaches and therapies to address heart failure. Eligible projects must represent a bona fide collaboration with at least 2 of 3 of the Centre’s partners: The Hospital for Sick Children, University Health Network, University of Toronto (any partners worldwide may be co-applicants). Contact: Linda Donovan, Planning & Operations Manager, linda.donovan@tedrogersresearch.ca. Deadline for Letters of Intent has been extended to: July 28, 2017 at 5pm. 
     
  • The Terry Fox Research Institute/Terry Fox Foundation.
    • The Terry Fox New Investigator Awards support outstanding new researchers as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration with established research teams. Deadline for Applications: September 8th, 2017.
    • The Terry Fox New Frontiers Program Project Grants support multidisciplinary teams of excellence that contribute to well-defined research topics of relevance to cancer. Deadline for Letters of Intent: August 8, 2017.
       
  • Leukemia & Lymphoma Society (LLS): Translational Research Program. The Translational Research Program puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma. The Leukemia & Lymphoma Society funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. Upper amount: $200,000 USD over 3 years. Grants are eligible for renewal. Deadline for Letters of Intent: September 29, 2017.
     
  • Vasculitis Foundation: Seed Funding. The purpose of this program is to provide seed grants to support pilot studies in researching: Etiology/Pathogenesis; Epidemiology, including genetics; Diagnosis, including identification of disease subtypes; and Treatment/Management, including therapeutics to treat vasculitis or prevent complications, biomarkers, and psychosocial outcomes. Upper amount: $50,000 USD per year for up to two years. This program funds research worldwide. Deadline for Applications: August 18, 2017.

  • Simons Foundation Autism Research Initiative (SFARI): SFARI Explorer Awards. Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder. Upper amount: $50,000 USD for one one year (non-renewable). Deadline for Applications: Continuous.
     

  • Frick Foundation for Research on ALS. The goal of the foundation is to provide research grants for the study of the understanding of the basic causes of amyotrophic lateral sclerosis (ALS). These awards are not directed to clinically related projects for patient care. There is no geographical limitation for the recipients of these grants. Upper amount: Fr100,000 CHF over two years. Deadline for Applications: September 30, 2017.
     

  • Mizutani Foundation for Glycoscience. The foundation provides research grants to outstanding proposals for basic and applied studies on glycoconjugate in the fields of organic chemistry, biochemistry, biophysics, molecular biology, cellular biology and medical sciences. The Foundation distributes grants to qualified scientists regardless of their nationalities or ethnic origins. Upper amount: ¥7,000,000 JPY total for up to three years. Deadline for Applications: September 1, 2017.


     

July 11, 2017

  • CIHR Project Grant: Fall 2017 Competition Launch and Webinars. As announced on July 10 by Dr. Rod McInnes, Acting President, changes have been made as a first step to improving the Project Grant competition. Read the full message. To support this funding opportunity, CIHR will be holding a series of Question and Answer webinars on the Project Grant: Fall 2017 application. Webinars will start on Thursday, July 20 and will provide participants with a brief overview of recent changes and an opportunity to ask questions. For more information and to register, please visit the CIHR Webinars page. Please note that the guidelines in ResearchNet are for both the Fall 2017 and the Spring 2018 competitions.
    • Registration period: July 11 to August 15, 2017
    • Application period: August 16 to September 15, 2017 (funding start date: April 2018)
       
  • Ted Rogers Centre for Heart Research: Innovation Fund Strategic Grants. The Ted Rogers Centre for Heart Research is now accepting submissions for its first-ever strategic grants, which provide funding of up to $1 million over 3 years for transformative research projects focused on discovery, development and implementation of next-generation approaches and therapies to address heart failure. Eligible projects must represent a bona fide collaboration with at least 2 of 3 of the Centre’s partners: The Hospital for Sick Children, University Health Network, University of Toronto (any partners worldwide may be co-applicants). Contact: Linda Donovan, Planning & Operations Manager, linda.donovan@tedrogersresearch.ca. Deadline for Letters of Intent: July 21, 2017 at 5pm. 
     
  • Healthy Behaviour Data Challenge. The Healthy Behaviour Data Challenge is an international partnership between Canada (CIHR and the Public Health Agency of Canada) and United States partners (the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services). The objective of the Healthy Behaviour Data Challenge is to identify and use creative new types of data and data sources to enhance public health surveillance of physical activity, sedentary behaviour and sleep. The challenge is being coordinated by the MaRS Discovery District. Register by August 4, 2017 to participate.
     
  • CIHR New Investigator Awards in Circulatory and Respiratory Health - PRE-ANNOUNCEMENT. These awards will provide early-career investigators from a variety of research backgrounds the opportunity to initiate and conduct research in the area of circulatory and/or respiratory health by providing protected research time via a stable salary base and operating funds. The maximum amount per award is $115 000 for up to three years for a total of $345 000. 
     
  • Epilepsy Foundation: New Therapy - Commercialization Grants Program.  The mission of this program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. Funding is provided to academic and commercial groups worldwide. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Deadline for Letters of Intent: July 21, 2017.
     
  • Progeria Research Foundation: Research on Hutchinson-Gilford Progeria Syndrome (HGPS, or Progeria). PRF will consider proposals in all areas directly relevant to Progeria. Two priority areas are 1. Discovery of biological markers of disease in HGPS that can be assessed in human and/or mouse samples; 2. Discovery and/or testing of candidate treatment compounds in both cell based and mouse models of HGPS. Awards are given in 3 categories: Innovator Awards, Established Investigator Awards, and Specialty Awards (for smaller, more technology-driven projects). Deadline for Proposals: September 19, 2017.

 

June 28, 2017

 

  • CIHR: Enrolment to the CIHR College of Reviewers began in June 2017. By forming the College, CIHR aims to enhance the current peer review system by systematizing reviewer recruitment to identify and mobilize the appropriate expertise for the review of all funding applications. The quality and diversity of the scientific expertise in the College will directly impact the quality of the review process of all of our CIHR funding proposals.  We strongly encourage you to nominate a colleague, or self-nominate. Acting CIHR President Roderick McInnes expressed the importance of a robust College of Reviewers in his recent visit to Toronto at the June 12th open dialogue hosted by the University of Toronto. If you’re interested in nominating, or learning more about the College – please contact college@cihr-irsc.gc.ca
  • CIHR: SPOR & JDRF Canada: Innovative Clinical Trials (iCT) in type 1 diabetes. As part of SPOR, the (iCT) initiative aims to build capacity and increase the intensity of iCT research. This funding opportunity is focused on the type of innovative clinical trials that involve comparative effectiveness research and/or implementation science research. The maximum amount per grant is $750,000 per year for up to four years for a total of $3,000,000 per grant. Deadline for Letters of Intent: August 8, 2017.
     
  • CIHR: SPOR Innovative Clinical Trial (iCT) Multi-Year Grant (2017). As part of SPOR, the iCT initiative aims to build capacity and increase the intensity of iCT research. iCTs use designs that are alternative to traditional Randomized Controlled Trials (RCTs) with application in areas ranging from product development to health system improvement. CIHR will provide funding for iCTs that have a primary focus in the research areas of comparative effectiveness research; and/or implementation science research. The maximum amount per grant is $375,000 per year for up to four years for a total of $1,500,000. Deadline for Letters of Intent: September 12, 2017.
     
  • NIH: Various Opportunities. Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • HIV/AIDS and the Tumor Niche (R01)
    • Addressing Suicide Research Gaps: Understanding Mortality Outcomes (R01)
    • Alcohol-Induced Effects on Tissue Injury and Repair (R21) and (R01)
    • Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
    • Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)
    • Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
    • Imaging the Persistent HIV Reservoir (R01)
    • Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)
    • Cellular and Molecular Biology of Complex Brain Disorders (R01) and (R21)
    • Global Brain and Nervous System Disorders Research Across the Lifespan (R21)  and (R01)
    • Multidisciplinary Studies of HIV/AIDS and Aging (R21) and (R01)
    • HIV/HCV Co-Infections in Substance Abusers (R01)
  • Cerebral Palsy Alliance: Career Development Awards. These awards are available to Early Career and Emerging in Field and to Mid-Career to Established in Field. Projects that address the causes, prevention, early interventions and cure of cerebral palsy will be rated more favourably when reviewing the merit of applications. Upper Amount $250,000 AUD. Citizenship or residency is unrestricted. Deadline for Applications: August 31, 2017.
     
  • MedEvac Foundation International: Research and Education Grants. The foundation awards funds to support the development of research and education in air medical and critical care ground transport. Studies that promote collaboration at the national or international level to complete the study or those that propose a critical review or meta-analysis of available evidence or salient work in a priority area are preferred. Deadline for Applications: July 28, 2017.
     
  • The Hope Foundation: SWOG/HOPE Foundation Impact Award. SWOG's mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. The SWOG/Hope Foundation Impact Award is a funding program that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. Upper amount $250,000 USD for up to two years. Deadline for Submissions: September 1, 2017.
     
  • Scleroderma Foundation: Established Investigator Grant. The Foundation seeks applications from promising individuals both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. Applicants may request up to $75,000 per year for up to two years. Deadline for Applications: September 15, 2017. 

June 13, 2107
 

  • NSERC Discovery Grant NOI Information Session. The mandatory Notice of Intent form for the 2018 Discovery Grant competition is now available through the NSERC Research Portal (deadline August 1, 2017). The University of Toronto will be holding an information session covering the following topics: the Notice of Intent, program requirements, eligibility requirements, Research Portal & Canadian Common CV, evaluation and proposal development.
    Date: Tuesday, July 18, 2017 from 2pm - 4pm
    Location: C. David Naylor Building, Room 6 (Imperial Oil Room), 6 Queen's Park Crescent West
    RSVP to joanna.baylon@utoronto.ca, (416) 978-2525
     
  • Brain Canada-Kids Brain Health Network Training Awards (Developmental Neurosciences Research). Brain Canada and Kids Brain Health Network have partnered together to offer predoctoral and postdoctoral training awards in developmental neurosciences. The awards will be made to outstanding predoctoral and postdoctoral fellows undertaking a program of research training that incorporates original research into the origins, early detection and effective treatment of disorders of brain development. Brain Canada will match on a 1:1 basis the funds put forward by eligible institutional sponsors to fund each training award. UofT applicants please visit here.  The deadline for potential applicants and their supervisors to have a finalized Supervisor/Departmental Letter of Support and to submit MRAs is June 20, 2017. 
     

  • CIHR PRE-ANNOUNCEMENT: Human Papillomavirus Screening and Vaccination Implementation in Underserved Populations - Catalyst Grant Funding Opportunity. This funding opportunity will focus on underserved populations (ie. Indigenous populations, Newcomers to Canada, Sex workers, injected-drug users, remote communities).  A specific pool will support at least two applications for research with Indigenous populations.  These must include relevant expertise in Indigenous Knowledge (including Two-Eyed Seeing and/or Indigenous Ways of Knowing), local governance systems and culturally appropriate services/approaches. Each team (for all applications), will have to include an appropriate knowledge user. Launch Date: July 2017; Full Application (Phase 1): September 2017.
     

  • CIHR PRE-ANNOUNCEMENT: Data Analysis Grants for Cancer Prevention and ControlThere are multiple databases and cohorts that have been well invested in and provide an excellent opportunity to answer novel research questions in a cost-effective manner.  The ICR data analysis grants are intended to support expert analyses of these existing data sets to advance knowledge in cancer control related to ICR’s three strategic priority areas.  The intent is to highlight large well-established cohorts such as the Canadian Partnership for Tomorrow Project, local and regional administrative databases) and encourage their utilization by the research community.  Large international databases (e.g., EPIC) may be used provided that the analysis occurs in Canada. Launch Date: Summer 2017; Full Application Deadline (Phase 1): Fall 2017.
     

  • The Terry Fox Research Institute: Program Project Grants Competition. The Terry Fox New Frontiers Program Project Grants support multidisciplinary teams of excellence that contribute to well-defined research topics of relevance to cancer.The purpose is to discover and explore new frontiers in cure-oriented cancer research. This RFA supports programs comprised of a minimum of three independent researchers and their research projects, and may also include one or more technology platforms that will be used by the projects. Support - New Applications of up to $750,000 per annum for a maximum of three years, and Renewing Applications of up to $1,500,000 per annum for a maximum of five years. Deadline for Letters of Intent: August 8, 2017. 
     

  • National MS Society. The U.S. based National MS Society has announced the following funding opportunities for the Summer of 2017.
     - Pilot Research Grants: One year grants that focus on unique or novel ideas with the potential to open significant new areas of research on multiple sclerosis. The maximum budget is $40,000 USD in direct costs. UofT Internal Deadline: July 7, 2017
    -  Research Grants: Multi-year grants involving basic, clinical and rehabilitation research for up to 5 years. Deadline for pre-applications: July 26, 2017; UofT internal deadline for full applications: July 28, 2017.
    UofT contact for this opportunity is krista.montgomery@utoronto.ca
     

  • Grand Challenges Canada: Stars in Reproductive, Maternal, Newborn & Child Health. This program seeks innovative ideas from applicants in low, middle-income countries and Canada, that seeks to address persistent challenges in reproductive, maternal, newborn and child health are addressed in low- and middle-income countries. Grand Challenges Canada will be funding proposals for up to $100,000 CAD for 12-18 months. UofT Internal Deadline: August 1, 2017: Proposal Deadline: August 3, 2017.
     

  • International Myeloma Foundation (IMF): Brian D. Novis Research Awards. These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis. This year's awards will be $50,000 each for the junior grant and $80,000 for the senior grant. Deadline for Submissions: August 1, 2017.

June 2, 2017

  • REMINDER! 2017 Workshop: Strategies for Grant Writing and Innovation. Join us to learn more about: Services available through our office, Innovation at the University of Toronto, and Grant Writing and Development.
    Hosted by the Office of the Vice Dean, Research and Innovation, Faculty of Medicine, UofT.
    Open to faculty, staff and post-doctoral fellows.
    Details here.
    Location: Medical Sciences Building, MacLeod Auditorium, Room 2158,  University of Toronto, 1 King's College Circle
    Date: Thursday, June 15, 2017 from 9:30am - 1:00pm
    Please register here if you have not done so already.
     
  • CIHR - Meet the President - An Open Dialogue. You are invited to an open session to meet the Canadian Institutes of Health Research (CIHR) Acting President, Dr. Roderick McInnes.  Dr. McInnes will be visiting the University of Toronto to discuss recent changes at CIHR, share his priorities, and answer your questions. All health researchers, research grants facilitators, and graduate students are invited to join. Dr. McInnes' talk will be webcast from the MacLeod Auditorium in the Medical Sciences Building. Instructions to join the webinar here.
    Location:  Medical Sciences Building, Room 2158 (MacLeod Auditorium), University of Toronto, 1 King's College Circle
    Date: Monday, June 12, 2017 from 10am – 11:30am
    *Please note that registration is not required and seating will be on a first come, first serve basis.
     
  • 2018 NSERC Discover Grant: Mandatory Notice of Intent (NOI) - Deadline: August 1, 2017.  As we approach the 2018 NSERC Discovery Grant competition, we wanted to inform all eligible NSERC Discovery grant applicants of the upcoming mandatory Notice of Intent (NOI).   NSERC has recently contacted all known potential applicants directly (including researchers on their last instalment of a Discovery Grant, or who applied unsuccessfully in the 2017 competition) to remind them of the upcoming August 1, 2017, 8 pm EST NOI deadline. The mandatory Notice of Intent form for the 2018 Discovery Grant competition is now available through the new NSERC Research Portal.  In order to apply for a Discovery Grant in November 2017, an applicant MUST complete and submit an online Notice of Intent by 8 pm EST on August 1, 2017.   If you do not submit a Notice of Intent by the deadline, you will NOT be eligible to apply in November for a 2018 Discovery Grant. 
    • NSERC is also hosting upcoming webinars for RTI applicants on June 20th and July 13th. Details here.
  • Compute Canada and CIHR Webinar: Tools for Data-Intensive Health Research. Need support to create data visualizations that increase the impact of your research data? How about help creating a cloud-based development space to support collaboration? Or to securely manage your research data? Compute Canada can provide support to mid- and smaller-scale data intensive projects, as well as large ones, in any discipline, and services are accessible across the country. Compute Canada and the Canadian Institutes of Health Research (CIHR) invite you to a webinar to learn about the advanced research computing resources and services available to the health research community. (English) June 13, 2017 from 2:30-3:30 ET. (French) June 16, 2017 from 2:30-3:30 ET. 
     
  • The Simons Foundation Autism Research Initiative (SFARI): 2017 Bridge to Independence AwardGrants awarded through this program are intended to invest in the next generation of top autism investigators by identifying talented early-career scientists interested in autism research and facilitating their transition to independent research careers. This RFA is aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the 2017–18 academic year. The program features a unique timeline in which the applicant submits their proposal as a postdoctoral fellow and receives their Bridge to Independence Award funding only once they assume a tenure-track professorship. Grantees receive a commitment of $150,000 per year for three years, awarded through their faculty-appointment institution. Deadline for first-stage proposals: August 7, 2017.
     
  • American Foundation for Suicide Prevention – Funding Opportunities. The Foundations priority areas for 2017-19 include: Pain and suicide; and opioids and suicide.
    • ​Focus Grants: For projects that are innovative, high-risk, potentially high-yield projects that focus on a specific area of suicide prevention. $500,000 per year for up to 3 years. Deadline for LOIs: August 1, 2017.
    • Linked to Standard Research Innovation Grants: For investigators at any level performing research involving two or more unique sites with each site contributing unique expertise, as well as data collection. $300,000 over 2 years. Deadline for LOIs: September 15, 2017.
    • Distinguished Investigator Grants: Up to $125,000 over 2 years. Deadline for applications: November 15, 2017.
    • Postdoctoral Research Fellowship Innovation Grants: Up to $104,000 over 2 years. Deadline for applications November 15, 2017.
    • Standard Research Innovation Grants: For individual investigators at any level. Up to $100,000 over 2 years. Deadline for applications: November 15, 2017.
    • Young Investigator Innovation Grants: For investigators at or below the level of assistant professor. Up to $85,000 over 2 years.
    • Pilot Innovation Grants: For investigators at any level, these grants provide seed funding for new projects that have the potential to lead to larger investigations. Up to $30,000 for up to 2 years. Deadline for applications: November 15, 2017.

May 26, 2017

  • OCE Health Technologies Fund - Call for Expressions of Interest. The Ontario Centres of Excellence (OCE) has launched the second round of a program being delivered on behalf of the Ministry of Health and Long-Term Care and as part of the Office of the Chief Health Innovation Strategist's (OCHIS) mandate to strengthen Ontario's health innovation system. The Health Technologies Fund (HTF) supports the development of made-in-Ontario health technologies by accelerating evaluation, procurement, adoption and uptake across the Ontario health system. The health priority area for the HTF is Better Care Closer to Home, which supports technologies that deliver better coordinated and integrated care in the home and community. Projects must be led by a publicly-funded healthcare service provider and include a Problem Statement that supports Pre-Market Evaluation or Early Adoption of an innovative technology. Internal Deadline: June 14, 2017; Sponsor Deadline: June 21, 2017. 
    • ​A project development webinar will be provided to support teams submitting an Expression of Interest (EOI) - please save the date: May 30, 2017, 10 -11 a.m.
       
  • INFO SESSION: MRIS - Early Researcher Award Round 13. The ERA program helps promising, recently-appointed Ontario researchers build their research teams of undergraduates, graduate students, post-doctoral fellows, research assistants, associates, and technicians. The ERA program will provide funding up to $100,000 for each award (plus $40,000 for indirect costs), and must be matched by an additional $50,000 (cash not in-kind) from the division/department and/or a partner organization. MRIS will be holding an information session for the ERA Round 13 on Wednesday June 7th, 2017 from 10am-11am. Please note that this information session is open to all research institutions in the area. LOCATION: Medical Sciences Building, Room 3153, 1 King's College Circle. 
  • ​NSERC Community Engagement Visit. NSERC community engagement visits provide researchers, students and other stakeholders an opportunity to learn more about some recent program and policy developments. NSERC engagement visits have been a successful tool for the Agency and the community to share information and build linkages. Over the last four years, NSERC officials have made 48 visits to 39 universities. Topics include highlights of the federal budget, 'Towards NSERC 2020', funding opportunity updates, and policy updates. The invitation is open to researchers, students and administrators from the University of Guelph as well as surrounding universities. 
    Location: OVC Pathobiology AHL, Room 1800, 50 Stone Rd. East, University of Guelph, Guelph, ON N1G 2W1 (map)
    Date/Time: Wednesday, June 14, from 9am - 12pm
    RSVP by June 6 to pminakis@uoguelph.ca
     
  • University of Toronto Early Stage Technology Program (UTEST): Sixth call for UofT companies. UTEST provides UofT start-up companies with seed funding of up to $50,000 in the form of a SAFE, 12 months of incubation space, intense entrepreneurial education provided by MaRS, mentoring and business strategy support. Deadline for Applications: June 2, 2017.
  • HUB Session: Essentials of Clinical Trials. This session will discuss the rationale and the essential elements of randomized clinical trials using practical examples. Topics covered will include confounding in observational studies, randomization, blinding and intention-to-treat analysis, choice of outcome and sample size considerations, and pragmatic trial designs. Registration is required.
    Date: Wednesday, June 7, 10am - 12pm
    Location: MS 2170, Medical Sciences Building, UofT, 1 King's College Circle

  • Juvenile Diabetes Research Foundation (JDRF) International:  Career Development Awards and Postdoctoral Fellowships. Career Development Awards are designed to assist exceptionally promising investigators. Although JDRF is especially interested in fostering careers in clinical investigation, Career Development Awards may emphasize either basic or clinical topics. Postdoctoral Fellows are designed to attract qualified, promising scientists entering their professional career in the T1D research field; intended for those in a relatively early state in their career. UofT Internal Deadline: June 23, 2017; Sponsor Deadline: June 28, 2017.

  • ​NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Novel Cell Non-autonomous Mechanisms of Aging (R01)
    • Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
    • Innovative Mental Health Services Research Not Involving Clinical Trials (R01)
    • Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01) and (R21)
    • Modeling of Infectious Disease Agent Study Research Projects (R01)
    • Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34) 
    • Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01)
    • Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01) and (R21)
    • Tobacco Regulatory Science (R01) and (R21)
    • HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21) and (R01)
    • In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01) and (R21)
    • Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21) and (R01)
    • Genomic Community Resources (U24)
    • NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
    • Silencing of HIV-1 Proviruses (R61/R33)
    • Addressing Suicide Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01)
    • HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01) and (R21)
  • International Fibrodysplasia Ossificans Progressiva Association (IFOPA): Competitive Research Grant Program. The program provides, through a competitive application process, research funding… more » to scientists conducting research on fibrodysplasia ossificans progressiva (FOP). Research grants should focus on discovery and advancement of new therapeutic approaches to FOP with preference towards approaches likely to have near-term clinical or translational relevance. Upper amount: $100,000 USD for one year. Deadline for Proposals: June 30, 2017.
     
  • Pfizer, Inc.: Global Research Awards for Nicotine Dependence (GRAND). The overall mission of the GRAND program is to advance the pharmacological treatment of tobacco and nicotine dependence. Research projects should aim to provide information that could directly advance the use of pharmacotherapy for treating users of any nicotine or tobacco product in clinical practice. Non-human studies and educational programs fall outside of the scope of the GRAND program for 2017 and will not be considered for an award. Upper amount: $200,000 USD. Deadline for Applications: July 3, 2017.
     
  • A-T Children's Project: Investigator Initiated Grants. The A-T Children's Project provides competitive grant awards for basic and translational research grants related to A-T. Please note that unless specific Requests for Applications are present, the A-T Children's Project is currently focusing its funding efforts on proposals that apply innovative and novel strategies for suggesting, developing and evaluating specific disease-modifying and symptomatic interventions with an emphasis on: pre-clinical research and clinical studies. Upper amount: $150,000 for up to two years. Deadline for Letters of Intent: August 1, 2017.
     
  • United States Department of Defense: Breast Cancer Research Program

May 11, 2017

  • 2017 Workshop: Strategies for Grant Writing and Innovation. Join us to learn more about: Services available through our office, Innovation at the University of Toronto, and Grant Writing and Development. 
    Hosted by the Office of the Vice Dean, Research and Innovation, Faculty of Medicine, UofT.
    Open to faculty, staff and post-doctoral fellows.
    Details here
    Location: Medical Sciences Building, MacLeod Auditorium, Room 2158
    Date: Thursday, June 15, 2017 from 9:30am - 1:00pm
    RSVP required. Register here.
     
  • CIHR/NSERC Collaborative Health Research Projects (CHRP): INFORMATION SESSION. The CIHR/NSERC CHRP program supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. CHRP projects require the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. ). Research Services Office, UofT, will provide an overview of the CHRP program and the application process including any internal U of T requirements.  Professor Craig Simmons, Distinguished Professor of Mechanobiology, and a multiple CHRP grantholder, will provide insight on the program from the researcher’s perspective as well as helpful tips learned from serving on the CHRP peer review committee.
    Location: Galbraith Buidling, Room 303, 35 St. George Street
    Date: Tuesday, May 16, 2017 from 2pm-3pm 
    RSVP to mark.bold@utoronto.ca by Friday, May 12.
     
  • NSERC Community Engagement Webinars. NSERC engagement visits have been a successful tool for the Agency and the community to share information and build linkages. Over the last four years, NSERC officials have made 48 visits to 39 universities. Moving forward, NSERC plans to continue connecting with the community in a more informal way.  NSERC is providing the Engagement visits in Webinar format as per the information below.
    (ENGLISH) Date: Wednesday, June 14, 2017, from 1pm - 3pm (ET)
    Conference number 1 877-413-4790
    Conference ID 7462843 7462843
    Link: http://nsercofcanada.adobeconnect.com/engagement-webinar/
     
  • Mitacs Elevate: Postdoctoral Fellowships, all disciplines. Mitacs Elevate is a postdoctoral fellowship with a customized research management training component. Mitacs Elevate is now accepting applications for two-year postdoctoral funding, which provides a $55,000 annual award (plus $7,500 per year non-cash value in training). Complete application information here. UofT Internal Deadline: May 31, 2017; Sponsor Deadline: June 7, 2017.
     
  • The Ted Rogers Centre for Heart Research - Education Fund (PhD/Fellowship): DEADLINE EXTENDED to May 12, 2017 at 5pm. Applicants must be enrolled as full-time students (as of Sept 1, 2017 or before) in a doctoral degree or postdoctoral research fellowship program, with involvement in cardiovascular research focusing on some aspect of heart failure. The proposed project must involve collaboration with at least 2 of 3 of the Centre’s partner organizations: Hospital for Sick Children (SickKids), University Health Network (UHN), and University of Toronto (UofT). Additionally, an applicant's supervisor must be affiliated with one or more of the partner organizations including other UofT affiliated academic health science centres, hospitals or research centres. 
     
  • Ministry of Research Innovation and Science (MRIS) Early Researcher Aware (ERA) - Round 13. The ERA program helps promising, recently-appointed Ontario researchers build their research teams of undergraduates, graduate students, post-doctoral fellows, research assistants, associates, and technicians. The ERA program will provide funding up to $100,000 for each award (plus $40,000 for indirect costs), and must be matched by an additional $50,000 (cash not in-kind) from the division/department and/or a partner organization. The funds are to be used over a period of five years to fund eligible expenses (e.g. salaries and benefits, essential and reasonable travel and expenses related to conferences for trainees, workshops, seminars, and/or offsite research activities) for building a research team. Eligible applicants are those who have started their academic career on or after July 1, 2012, and have completed their first Doctor of Philosophy, Doctor of Veterinary Medicine degree, Medical Doctor or terminal degree on or after July 1, 2007. The program will take into consideration eligible disruptions (such as required training and parental leave). UofT Deadline for NOIs: June 30, 2017. Please visit here for further details and how to apply.
     

May 3, 2017

  • NOTE -THIS COMPETITION* HAS BEEN DELAYED. Further information will be posted when available.
    *CIHR Project Grant Program: Spring 2017 Competition. Information for UofT, Faculty of Medicine, campus-based applicants (REMINDER)
    If you: a) will be submitting a proposal to this competition, b) will be administering your grant through a unit within the Faculty of Medicine, and c) wish to receive an editorial review of your proposal from our office, we ask that you submit your draft proposal to Grants and Awards Editor Daniel Harney –dan.harney@utoronto.ca – by Tuesday May 23rd. We acknowledge that this is ahead of the registration deadline (May 30th), but with CIHR only giving two weeks between the registration and application deadlines, this internal deadline is essential to allow time for a proper review. Please note that CIHR's anticipated notice of decision for the Fall 2016 competition is May 15, 2017. CIHR registration deadline: May 30, 2017  CIHR submission deadline: June 13, 2017 
     
  • University of Toronto: Connaught Global Challenge Award 2017-18 (REMINDER). The Global Challenge Award program will support new collaborations with UofT researchers and students from multiple disciplines, along with innovators and thought leaders from other sectors, with the goal of heightening the University of Toronto's contribution to important issues facing society through the advancement of knowledge, and the transfer and application of solutions. Awards will support symposia, workshops, visiting scholars, and other mechanisms for bringing diverse sets of expertise to bear on important global challenges. Open to all UofT full-time professorial staff (tenured or tenured stream), the funding scheme will have an annual funding envelop of $750,000, with grants up to $250,000 each. Application Deadline: June 1, 2017.
     
  • CIHR/NSERC Collaborative Health Research Program (CHRP). The CHRP Initiative funding supports innovative, interdisciplinary, collaborative research projects, requiring participation from the natural sciences or engineering community together with the health sciences community. The CHRP Initiative funding requires the translation of the research results to knowledge/technology users (KTUs) and related stakeholders outside the academic or training environment. As such, the proposed research projects must have a strong focus on knowledge translation (KT) and lead to health and economic benefits for Canadians, more effective health services and products, and/or a strengthened health care system. KTU organizations should be meaningfully engaged throughout the research process, as appropriate, to inform research planning and design. UofT Internal Deadline: May 30, 2017; Deadline for LOIs due at CIHR: June 6, 2017. Full applications will be by invitation only.
     
  • Genomic Applications Partnership Program (GAPP) - Round 9. The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that promote the commercialization and translation of genomics-derived technologies which address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and tools. The program provides a unique opportunity for Receptor organizations to collaborate with an ’omics researcher, and to leverage their R&D investments with public funding. Visit here for details on how to apply and further information. Deadline for EOIs to Ontario Genomics and UofT: May 15, 2017 at 9am ET.
     
  • Mitacs Globalink Research Internships 2018. The Mitacs Globalink Research Internship (GRI) program is now accepting Faculty submissions for Summer 2018. GRI pairs Faculty in Canada with international undergrads for 12-week research projects from May to September. All disciplines are eligible. Top-ranked senior undergrads travel from Australia, Brazil, China, France, Germany, India, Mexico, Tunisia, and Saudi Arabia. Faculty can submit multiple projects and re-submit projects from previous years. UofT Internal Deadline: June 7, 2017; Sponsor Deadline: June 14, 2017. 
     
  • Westin Brain Institute - Canada: Rapid Response 2017. Seed funding to support novel, high-risk, high-reward translational research that accelerates the development of therapeutics for neurodegenerative diseases of aging. Up to $200,000 per project, for up to 18 months. Deadline for PD-related disease applications: May 9, 2017; Deadline for AD-related disease applications: July 5, 2017.
    INFORMATION WEBINAR
    (AD-related diseases): June 12, 2017 at 1pm ET. Register here.
     
  • The Myositis Association: Grants & Fellowships 2017.  Funding is available for research into any type of immune-mediated myositis. Fellowship funding is available for $50,000 per year for 2 years, and grant funding is available for a maximum of $75,000 per year for 2 years. Research grants support new or innovative myositis research projects. Research fellowships support a a young physician, or PhD scientist, who is beginning a career in myositis research in the laboratory of an established myositis investigator. Deadline for LOIs: May 15, 2017. Full applications due: June 16, 2017.
     
  • National  Centre for Responsible Gaming (NCRG): Gambling Disorders Research Funding. The NCRG is committed to a multi-disciplinary approach and, therefore, welcomes applications from investigators in psychology, psychiatry, epidemiology, public health, sociology, economics, neuroeconomics, neuroscience and other relevant disciplines. Funding is available for travel grants, seed funding and large grants. Deadline for LOIs (large grants): June 1, 2017; Deadline for applications (seed grants): August 1, 2017.
     
  • Alex's Lemonade Stand Foundation for Childhood Cancer (ALSF): Familial RUNX1 Patient Samples Grant. The purpose of the grant is to fund research in strategies leading to the development of therapies to prevent the transition from pre-leukemia to leukemia for patients with FPD/AML. Projects should focus on leukemia caused by familial RUNX1 mutations rather than sporadic AML with somatic RUNX1 mutations.  Funding and grant duration depend on the research direction of interest but range between $250,000 and $500,000 USD over two years. Deadline for LOIs: July 1, 2017; Full Application Deadline: September 15, 2017.
     
  • The Hope Foundation: SWOG Early Exploration and Development (SEED) Fund. SWOG's mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer, and to enhance the quality of life for cancer survivors, primarily through design and conduct of clinical trials. Awards are made from The Hope Foundation SEED Fund to encourage preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). Individual projects may be funded for up to $50,000 USD (direct costs) and may be spent over a 1- or 2-year award period. Deadline for Applications: July 1, 2017.
     
  • Histiocytosis Association: Research Grants. Proposals for scientific research (both basic and clinical) are accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Proposals are evaluated on the basis of science, feasibility, and relevance. All proposals are expected to address one or more of the histiocytic disorders. Upper amount $50,000 USD. Deadline for Applications: July 1, 2017.

April 19, 2017

  • CIHR Announcement: Dr. Anne Martin-Matthews to serve as Acting Vice-President, Research, Knowledge Translation, and Ethics of CIHR. 
     
  • Message from Roderick McInnes, Acting President of CIHR. Changes to the upcoming Spring 2017 Project Grants competition and news about the Fall 2016 Project Grants competition.
     
  • Investing in Canada’s Future: Strengthening the Foundations of Canadian Research. Last June, Minister of Science Kirsty Duncan appointed an independent panel to review the Government of Canada’s funding mechanisms for fundamental science. Chaired by Dr. David Naylor, the esteemed panel criss-crossed the country to collect input from researchers, scientists, students and the Canadian public. The report is now available.
     
  • The CIHR Foundation Grant Program – Why and when you should apply: IHDCYH Webinar Series. Are you interested in applying for the Foundation Grant Program, but aren’t sure if it is the right decision for you? This webinar will help you identify whether this opportunity is right for you by reviewing key elements of the application process, including eligibility, how existing funding is dealt with, and how a foundation grant affects your current funding and ability to apply for other funding. The webinar will also include a Q&A session where we will discuss any issues and barriers to submission that you may be experiencing.
    • WEBINAR: May 2 at 1pm EST (register in advance) or
    • WEBINAR: May 15 at 2pm EST (register in advance)
  • Broad Institute: CARB-X Collaborative Hub for Early Antibiotic Discovery. The Collaborative Hub for Early Antibiotic Discovery (CHEAD) at the Broad Institute supports CARB-X by acting as an interdisciplinary center for early stage development of molecules identified by academic investigators engaged in antibiotic development and/or resistance research. CHEAD will partner with academic laboratories to evaluate and accelerate the development of promising small molecule therapeutics toward Investigational New Drug/Investigational Device Exemption (IND/IDE) application. Deadline for Applications: May 1, 2017.
     
  • amFAR: Mathilde Krim Fellowships in Basic Biomedical Research. The goal of amfAR's Mathilde Krim Fellowships in Basic Biomedical Research is to facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic or non-profit institution. Applicant fellows and mentors need not be U.S. citizens. Maximum funding is $150,000 for 2 years. Deadline for LOIs: May 9, 2017 at 3pm EDT.
     
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): Computational Tools for PD Therapeutic Development. MJFF aims to support development of computational tools to facilitate production of novel biomedical measures relevant to defining PD. The following disciplines of computational methods are encouraged: Data processing functions to allow for enhanced analysis efficiency, and multi-modal statistical and computational methods. $150,000 USD for one year. Deadline for Preliminary Proposals: May 31, 2017.
     
  • Osteology Foundation: Osteology Researcher Grants. Funding research into all aspects of oral tissue regeneration is a core task of the Osteology Foundation. Studies are the engine of development. The Osteology Foundation provides funding for studies all over the world. The foundation provides Osteology Advanced Researcher Grants and Osteology Young Researcher Grants. Grants are limited to 100'000 or 30'000 Swiss francs with a maximum project duration of two years or one year, depending on the grant program. Deadline for Abstract Submissions: June 15, 2017.
     
  • Lung Cancer Research Foundation (LCRF): Research Grants. The Foundation encourages applications for projects investigating a wide variety of research topics, including:  Prevention and screening for early detection; Identification of new biomarkers and the development of targeted therapies; The development of next-generation chemotherapeutic agents; Supportive measures for people with lung cancer and their families; and Quality of care and outcomes research. Upper amount: $150,000 USD over 2 years. Deadline for Applications: July 1, 2017.
     
  • Alzheimer's Drug Discovery Foundation (ADDF):  Accelerating Drug Discovery for Frontotemporal Degeneration (Request for Proposals). Research investigating the pathologic mechanisms underlying frontotemporal degeneration (FTD) is advancing, creating new targets for drug discovery. The foundations seek to accelerate and support innovative drug discovery programs for FTD through this Request for Proposals (RFP). Upper amount: $150,000 USD for one-year. Deadline for LOIs: July 31, 2017.
     
  • Solving Kids' Cancer (SKC): Therapeutic Development Initiative (TDI) - Funding for High-Impact Pediatric Cancer Research. The TDI of SKC only supports clinical research. The organization specifically focuses on novel clinical studies for neuroblastoma, brain tumors and sarcomas. Priority is given to proposals that introduce therapeutic agents and modalities which are first-in-children and have a strong potential to improve treatment outcomes. Funding award amounts generally range from $50,000 to $600,000 USD for up to 2 years. Deadline for Preliminary Proposals: Continuous.
     
  • Jain Foundation: Research Grants. The explicit goal of the Foundation is to expedite development of a treatment or cure for the dysferlinopathies (LGMD2B and Miyoshi Myopathy). A proposed project must have application to these diseases, or it will not be considered. The project must have direct relevance to dysferlin deficiencies - either to extend the understanding of the disease or a unique approach to a treatment for the disease. Deadline for Preliminary Proposals: Continuous.
     
  • ​NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) and (R21)
    • Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) and (R21) and (R01)
    • Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)
    • Innovative Research in Cancer Nanotechnology (IRCN) (R01)
    • Dysregulation of Immune Cell Regulatory Pathways by Mtb in the Context of HIV Infection (R61/R33)
    • Extracellular Vesicles and Substance Use Disorders (R01) and (R21)
    • Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
    • Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
    • Integrative Computational Biology for Analysis of NHLBI TOPMed Data (R01)
    • From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01) and (R01)
    • Collaborative R01s for Clinical Studies of Mental Illness Not Involving Clinical Trials (Collaborative R01)

April 12, 2017

  • CFI - Cyberinfrastructure Initiative. The Canada Foundation for Innovation (CFI) has published the Call for Proposals for the second competition of Challenge 1 of the Cyberinfrastructure Initiative. In this competition, the CFI challenges institutions and researchers to come together to form consortia and propose research data infrastructure projects that create tailored, shared and integrated data resources (e.g. databases and data repositories) capable of enabling leading-edge research on significant scientific, social and economic questions. Projects submitted should bring together a community of researchers from across the country who share similar challenges linked to the availability of research data. Projects should address an existing or emerging challenge for this community through the development of new tools and applications or novel ways of organizing and using research data that would enhance the community's capacity to conduct leading-edge research. English WEBINAR to be held on April 26, 2017; French WEBINAR to held April 27, 2017. Details are forthcoming.
    UofT Internal deadline to submit NOIs: May 4, 2017; Sponsor deadline for NOIs: May 12, 2017. Visit the UofT webpage for complete timelines. 
     
  • CIHR Team Grant : Healthy Life Trajectories Initiative (HeLTI) - Canada. This funding opportunity is part of the HeLTI initiative, the goal of which is to shape national policy and decision-making around interventions during the earliest stages of life for the improvement of health and the prevention of later life non-communicable diseases, including cardiovascular diseases, diabetes, respiratory diseases and mental health. Thiscohort will align with the HeLTI Initiative’s Linked International Intervention Cohorts (HeLTI LIIC). Deadline for Applications: June 13, 2017. 
    • Information WEBINAR: April 21, 2017 at 12pm ET. Please register in advance.
       
  • CIHR: HIV/AIDS Comorbidities Prevention and Healthy Living Team Grants. The goal of the HIV/AIDS Comorbidities Prevention and Healthy Living Team Grants is to improve the health of people living with HIV/AIDS in Canada by supporting the development or enhancement of expert teams of investigators and their partners undertaking strategic collaborative, multi-disciplinary biomedical and clinical research relevant to the CIHR HIV/AIDS Strategic Plan. View the call in ResearchNet. Deadline for LOIs: June 20, 2017. 
  • The Westin Brain Institute: Postdoctoral Scholars 2017. This program provides salary support to top-tier Canadian postdoctoral scholars for international training at the University of Oxford, and affiliation with Merton College. The application deadline has been extended to July 26, 2017 at 2:00pm EDT, to provide more time for applicants to develop a strong collaboration and experimental approach with their potential supervisor at Oxford. The Award amount is £57,000/year (£44,000/year + benefits) for 2 years.
    • Information WEBINAR: May 16, 2017 from 1pm-2pm EDT. Register here.
  • Rettsyndrome.org - International Rett Syndrome Foundation: Research Grants Opportunities
    • Neuro-Habilitation Research Grant Program. Upper amount: $150,000 USD for 2 years. Deadline for LOIs: May 1, 2017
    • Translational Research Grant Program: HeART (Help Accelerate RTT Therapeutics). Upper amount: $150,000 USD for 2 years. Deadline for LOIs: May 8, 2017
    • Basic Research Grants. Upper amount: $150,000 USD for 2 years.​ Deadline for LOIs: May 22, 2017
    • Mentored Training Fellowships. Upper amount: $100,000 USD for 2 years.​​ Deadline for LOIs: June 5, 2017
  • ​Lam Foundation: Grants Opportunities. The LAM Foundation offers grant opportunities for researchers interested in studying lymphangioleiomyomatosis.  Deadline for LOIs: June 15, 2017. The LAM Foundation offers the following research awards and grants:  
    • Career Development Awards. Upper amount: $50,000 USD for up to 3 years.
    • Established Investigator Awards. Upper amount: $50,000 USD for up to 3 years.
    • Pilot Project Awards (available for the initiation of innovative research projects). Upper amount: $25,000 USD
    • Other awards (The LAM Foundation also considers proposals for clinical trials, bridge funding and other special projects.) 
       
  • Saving tiny Hearts Society (StHS): Research Grants. The Society awards research grants to early stage science with unique hypotheses fostering the next generation of congenital heart defect research creating a strong foundation of preliminary evidence to make scientific advancements. Priority will be given to well-designed hypothesis driven research that will impact the lives of children and adults living with congenital heart disease.  Upper amount: $75,000 USD for one year. Deadline for Proposals: July 15, 2017.
     

April 4, 2017

  • CIHR Announcement - Roderick McInnes: Acting President of CIHR. On March 31, 2017, the Honourable Jane Philpott, Minister of Health, announced that Dr. Roderick McInnes has assumed the responsibilities of Acting President of the Canadian Institutes of Health Research (CIHR).  Dr. McInnes is an internationally recognized researcher who brings extensive leadership experience to CIHR, having served as the inaugural Scientific Director of the Institute of Genetics, from 2000-2010. ​Dr. McInnes replaces Dr. Alain Beaudet, who was appointed as CIHR President in 2008.  In this acting assignment, Dr. McInnes will lead the organization until a permanent President is appointed by the government.
     
  • CIHR/SSHRC: Healthy and Productive Work - Partnership Grants. This initiative supports the development, implementation, evaluation and scaling up of evidence-based interventions (e.g. accommodations, tools and policies) taking into consideration sex, gender, age, and physical and mental health, to ultimately foster healthy, meaningful and productive work for all workers. View the full call in ResearchNet. Deadline for Applications: November 1, 2017.
     
  • Neuroscientist Catalyst Program. Neuroscience Catalyst is a public-private partnership between the University of Toronto, Janssen Inc. and the Johnson & Johnson Innovation center in California to fund collaborative pre-competitive, early-stage proof of concept research towards identifying and validating new therapeutic targets that can progress to the clinical treatment for mood disorders and Alzheimer’s disease. Neuroscience Catalyst was designed with the aim of leveraging the collective skills and resources of academia and industry to accelerate the pace of developing and bringing new neuroscience drugs to market and providing treatments for major brain disorders. The program is currently accepting applications on a rolling basis until July 14, 2017.
     
  • National Research Council of Canada (NRC): Postdoctoral Fellow Program. The NRC is excited to announce a new initiative to bring up to ten postdoctoral fellows (PDFs) to work alongside our internationally recognized research leaders. The program will offer PDFs access to unique world-class facilities and the opportunity to work alongside multi-disciplinary teams of expert researchers and technicians on projects of critical importance to Canada. PDFs will carry out research on innovative research projects, with opportunities for career development (publications and/or industry interaction). Deadline for Applications: April 23, 2017. 
     
  • Advancing Science Through Pfizer: Investigator Research Exchange (ASPIRE) Gene Therapy for Hemophilia Research Awards Program. The mission of the program is to support research through a competitive grants program that advances medical knowledge in the area of Gene Therapy for Hemophilia. The 2017 program will focus on Hemophilia B. Upper amount $250,000 USD for 1-2 years. Deadline for Applications: May 22, 2017.
     
  • Huntington's Disease Society of America (HDSA): HD Human Biology Project. HDSA is interested in sponsoring innovative lines of inquiry of human HD patient data that will shed light on the most proximal biological events caused by the mutant huntingtin gene. All research proposals must incorporate a patient-centric focus to understanding HD. Upper amount: $150,000 USD for up to two years. Deadline for Letters of Intent: May 22, 2017.
     
  • Lupus Research Institute (LRI): Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity. This a global program that will provide outstanding scientists with substantial support for up to four years to conduct novel research into the fundamental causes of lupus and so provide new directions toward a cure or prevention.  The  LRI welcomes novel, hypothesis- or discovery-driven proposals in human and/or animal model based lupus research. The research proposal must aim to uncover the fundamental causes of lupus and present a compelling vision of how the discovery would lay the groundwork for a potential cure, prevention, or highly effective therapy. Upper amount $1,000,000 USD for up to four years. Deadline for Applications: May 24, 2017.
     
  • Michael J. Fox Foundation for Parkinson's Research (MJFF): Inflammation Biomarkers for Parkinson's Disease (NEW). MJFF seeks to support research that will develop new or improve upon existing biomarker tools for neuroinflammation/peripheral inflammation in Parkinson's disease (PD). Visit their website to view their specific goals, modalities and subtopics. Upper amount $300,000 USD for 1-2 years. Deadline for Pre-proposals: May 31, 2017.
  • Care-for-Rare Science Award 2017. Endowed with 50,000€, the Care-for-Rare Science Award, sponsored by the Werner Reichenberger Foundation, aims to give scientists the chance to initiate a basic or clinical research project in the field of rare diseases. The Care-for-Rare Foundation supports interdisciplinary and international scientific projects with the goal to elucidate the causes of rare diseases and to develop new innovative therapies for affected children. The application is open for single persons or groups of scientists with at least one member being affiliated with a research institution located in Germany. Junior researchers are explicitly encouraged to apply. For further information please contact Dr. Henrike Klinker.  Deadline for Submissions: July 2, 2017.
     
  • JDRF Strategic Research Agreement: Single-, Multi-, and Clinical SRA Projects. JDRF’s Strategic Research Agreements provide research funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research. The Strategic Research Agreement is a partnership between Investigator(s) and JDRF Scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation. Deadline for Project Concept: August 1, 2017.
     

 

March 24, 2017
 

  • CIHR Project Grant Program: Spring 2017 Competition. Information for UofT, Faculty of Medicine, campus-based applicants. If you: a) will be submitting a proposal to this competition, b) will be administering your grant through a unit within the Faculty of Medicine, and c) wish to receive an editorial review of your proposal from our office, we ask that you submit your draft proposal to Grants and Awards Editor Daniel Harney – dan.harney@utoronto.caby Tuesday May 23rd. We acknowledge that this is ahead of the registration deadline (May 30th), but with CIHR only giving two weeks between the registration and application deadlines, this internal deadline is essential to allow time for a proper review. Please note that CIHR's anticipated notice of decision for the Fall 2016 competition is May 15, 2017.
    • CIHR registration deadline: May 30, 2017
    • CIHR submission deadline: June 13, 2017
       
  • ​CIHR Foundation Grant Program: 2017-2018 Competition. CIHR has officially announced the timelines for the next Foundation Grant Program (2017-2018). Compete details are now available in ResearchNet.
    • Registration deadline: August 8, 2017
    • Stage 1 application deadline: September 12, 2017
       
  • ​​​Diabetes Canada: 2017 Research Competition. Previously Diabetes Canada (formerly Canadian Diabetes Association) funded two separate annual research competitions: a Personnel Awards competition—which was comprised of three categories: Clinician Scientist Awards, Scholar Awards, and Post-Doctoral Fellowship Awards—and an Operating Grants competition. Under the redesigned research funding model, there will no longer be two research funding competitions. Instead, there will be one integrated research competition. The categories for this competition will be:
    • Post-Doctoral Fellowship: Salary support of $45,000 per year, plus a research allowance of $5000 per year, with a duration of funding of up to three years.
    • New Investigator Award: $125,000 per year for three years. Of this, the investigator may choose to allocate up to $50,000 per year for investigator's salary support.
    • Diabetes Investigator Award: $125,000 per year for five years (successful applicants who wish to use part of the award for salary will be asked to submit specific justification for review).
      • UofT internal (MRA) deadline (for institutional signatures): March 29, 2017
      • Sponsor deadline: April 3, 2017 at 8pm EDT through ResearchNet
  • Joule Innovation Grant Program: Physician-Led Innovations. As a Canadian Medical Association (CMA) company, JouleTM provides physicians with valuable products and services to help them perform at their best. Joule is uniquely positioned to advance physician-led innovation through grant funding, access to mentorship and knowledge-sharing opportunities. Through the Joule Innovation program, CMA members have access to $150,000 in flexible funding to invest in their venture where they need it most—to build a prototype, to commercialize, to scale their initiative—the possibilities are endless. Questions about Joule and the grant program should be directed to Kyle.brown@cma.ca, Senior Advisor, Business Intelligence & Strategy, tel: 613-266-0194.
    • UofT Internal Deadline: April 24, 2017
    • Deadline for Applications: May 1, 2017
       
  • NIH Various Opportunities.  Unless otherwise stated in the funding opportunity, see Standard Due Dates Schedule for deadlines for each Grant category. If you intend to apply via the University of Toronto, it is recommended you contact Krista Montgomery in Research Services at least two weeks prior to submitting an NOI or application.  For more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
    • Research Answers to NCI's Provocative Questions (R01) and (R21)
    • Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)
    • Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)
    • Neuroskeletal Biology of the Dental and Craniofacial Skeletal System (R01) and (R21)
    • Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21) and (R01)
    • Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01) and (R21)
    • From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01) and (U01)
    • NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)
    • Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) and (R03) and (R01)
    • Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01)
    • NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)
    • NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)
    • Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01) and (R21) and (R03)
    • Hearing Health Care for Adults: Improving Access and Affordability (R01)
    • Nutrition and Alcohol-Related Health Outcomes (R01) and (R03) and (R21)
    • Inter-organelle Communication in Cancer (R01) and (R21)
    • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3)
    • Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01)
    • Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01)
    • Mechanisms of Alcohol-associated Cancers (R21) and (R01)
       

 

Back to Top